Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Nasdaq Biotechnology Ishares ETF (NQ: IBB)
105.55 USD  +0.92 (+0.88%)
Official Closing Price  /  Updated: 5:35 PM EDT, Sep 20, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Nasdaq Biotechnology Ishares ETF
Sector
Exchange Traded NQ
Net Assets 9.18B
Inception Date
Related Funds
Quote
Price 105.55
Volume 3,298,700
Last Trade Sep 20, 5:35pm
Change (%)
+0.92 (0.88%)
Prev. Close 104.63
YTD %
+8.26%
Dividend Yield 0.30%
Performance
YTD
+8.05 (8.26%)
1 Month
+3.14 (3.07%)
3 Month
-1.53 (-1.43%)
6 Month
-2.77 (-2.56%)
1 Year
-14.41 (-12.01%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Week Ahead In Biotech: Spotlight On ESMO Conference
Biotech stocks put up a muted performance in the week ended Sept. 20 amid conference presentations and FDA approvals. Johnson & ... Read More
from Benzinga
Somewhere Over The Market Rainbow
The most exciting aspect of rainbows, is that they are ephemeral. Lucky for us when we get to see them. Is that the same with the market--ephemeral and lucky when we get to trade a rally? Read More
from Blogs - TalkMarkets
Top News
More News
Flashback To The 70’s
Global equity markets had a moment of self doubt and most country ETFs backed off after digesting lower rates in the US. The thinking behind the tepid market response had some logic as the Fed stated... Read More
from Blogs - TalkMarkets
6 September Healthcare IPOs Investors Should Take Stock Of
The recent crop of new stocks runs the gamut from R&D stage biotech to a Fortune 500 spin-off with billions in revenue. Read More
from Motley Fool
The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
IBB, VRTX, ILMN, BIIB: Large Inflows Detected at ETF
Symbols mentioned in this story: IBB, VRTX, ILMN, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
from ETF Channel
IBB's Underlying Holdings Could Mean 33% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Sell on the Pop Prospects: September 18 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts
The following isa roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks ... Read More
from Benzinga
The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
3 Top Biotech Stocks to Buy in September
These three biotech stocks could be great buys this month. Read More
from Motley Fool
A Glimpse Into The Week With The Silver To Gold Ratio
The metals, in all the ongoing uncertainty, crashed last week amid geopolitical and economic data news. So when is safe to get back into metals? Read More
from Blogs - TalkMarkets
Is iShares Nasdaq Biotechnology Index Fund a Buy?
If you lack the time or technical knowledge to invest in biotech, this might be the fund for you and your diversified portfolio. Read More
from Motley Fool
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Biotech stocks rebounded in last week after declining modestly in the previous week. Some of the drugs that cleared the FDA hurdle ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.